[Federal Register Volume 69, Number 200 (Monday, October 18, 2004)]
[Notices]
[Page 61357]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-23231]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Provisional Patent Application Concerning Small 
Molecule Inhibitors of Botulinum Toxin

AGENCY: Department of the Army, DoD.

ACTION:  Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is 
made of the availability for licensing of the invention described in 
U.S. Provisional Patent Application Serial No. 60/501,243 entitled 
``Small Molecule Inhibitors of Botulinum Toxin,'' filed September 8, 
2003. The United States government, as represented by the Secretary of 
the Army, has rights in this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA-Z, 504 Scott Street, Fort 
Detrick, Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 04-23231 Filed 10-15-04; 8:45 am]
BILLING CODE 3710-08-M